Revenue segments as reported by the company.

Instruments & Accessories

Systems

Services

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

SG&A

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Intuitive Surgical

Intuitive Surgical, Inc. engages in the development, manufacture, and marketing of da Vinci Surgical Systems, and related instruments and accessories for invasive surgery. Its products include Da Vinci and Ion. The company was founded by Frederic H. Moll, John Gordon Freund, and Robert G. Younge in November 1995 and is headquartered in Sunnyvale, CA.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Intuitive Surgical reports robust Q4 performance and eyes future growth

Intuitive Surgical's Q4 2022 showcased strong performance and growth in procedures and system placements.
While facing challenges like macroeconomic uncertainty and supply chain costs, the company is poised for continued innovation.
Opportunities lie in expanding markets, advancing technology, and improving surgical outcomes through collaboration.
Investments in industrial scale, automation, and platform advancements signal a strategic focus on future growth.

Intuitive Surgical (ISRG) reports robust Q1 performance and growth outlook

Intuitive Surgical (ISRG) delivered strong Q1 results with revenue up 14% and exceeding procedure growth expectations.
While facing challenges in manufacturing and supply chain, the company is focusing on R&D progress and inventory replenishment.
The outlook for 2023 looks promising with increased procedure growth forecasts and a focus on improving patient outcomes and market expansion.
Overall, Intuitive Surgical (ISRG) is well-positioned to capitalize on opportunities for growth and innovation in the robotic surgery market.

Intuitive Surgical excels in Q2 performance, eyes AI opportunities

Intuitive Surgical's Q2 2023 performance showcased strong revenue growth, procedure increases, and a focus on healthcare improvement.
The company's strengths include innovative ecosystem investments, commitment to patient outcomes, and advanced surgical technologies.
Challenges include market disruptions from new drugs, expense management, and adapting to changing healthcare landscapes.
Opportunities in AI, market expansion, and new procedures position Intuitive Surgical for continued growth and innovation.

Intuitive Surgical excels in Q3, eyes global expansion and margin growth

Intuitive Surgical's Q3 performance reflects strong growth and strategic focus on innovation and market expansion. Despite challenges in specific procedure categories and pricing dynamics, the company is well-positioned to capitalize on opportunities for growth and margin improvement.

Intuitive Surgical posts strong 2023 results, da Vinci 5 launch ahead

Intuitive Surgical's 2023 performance reflects strong revenue growth, operational excellence, and a strategic focus on innovation with the upcoming da Vinci 5 launch.
While facing challenges in operating margin pressure and supply chain issues, the company is well-positioned to capitalize on opportunities in soft tissue surgery, big data integration, and leased placements.
Investors should monitor how Intuitive Surgical navigates the launch of da Vinci 5, manages operational challenges, and leverages growth opportunities to sustain its market leadership.
Overall, Intuitive Surgical's Q4 earnings call highlights a resilient business model, customer-centric approach, and a commitment to advancing surgical technology for better patient outcomes.

Intuitive Surgical posts robust Q1 results amidst global market challenges

Intuitive Surgical delivered strong Q1 results with notable procedure and revenue growth, despite challenges in certain markets.
The company's focus on newer platforms, operational efficiency, and strategic outlook for 2024 positions it for continued success.
Addressing challenges and seizing opportunities in global markets and product innovation will be key for sustained growth and competitiveness.

Intuitive Surgical excels in Q2, eyes global expansion and innovation

Intuitive Surgical's Q2 performance reflects strength in procedure growth and system platform advancements.
The company's commitment to innovation and value creation positions them well for future success.
Challenges include sustaining margins and navigating market dynamics, while opportunities lie in expansion and innovation.
Overall, Intuitive Surgical's focus on growth, technology, and patient care sets a positive trajectory for the future.

Intuitive Surgical excels in Q3 with strong growth and innovation

Intuitive Surgical's Q3 2024 performance reflects a company in a strong position with notable achievements in procedures, financials, and technological advancements. While facing challenges in margin progression and international expansion, the company is well-positioned to leverage opportunities in innovation and customer insights.

Revenue

Cost of revenue

Gross profit

Operating expenses

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Intuitive Surgical, Inc. engages in the provision of robotic-assisted surgical solutions and invasive care through a comprehensive ecosystem of products and services. Its products include Da Vinci Surgical and Ion Endoluminal systems. The company was founded by Frederic H. Moll, John Gordon Freund, and Robert G. Younge in November 1995 and is headquartered in Sunnyvale, CA.

Shopify

These companies could turn your portfolio into a money machine.

2 Unstoppable Stocks to Buy No Matter What Happens in 2021

ABB Ltd.

Rockwell Automation

Toyota Motor

KION Group AG

With the recovery path from the novel coronavirus pandemic expected to be a tough one, automation stocks are on the radar for their connection to cost savings and improved efficiencies. The post 7 Automation Stocks Levered To Innovation, Growth and Competitive Advantage appeared first on InvestorPlace.

7 Automation Stocks Levered To Innovation, Growth and Competitive Advantage

Intuitive Surgical is down more than 7% since the start of this year. Does this present a buying opportunity or is it the harbinger of more bad news?

Is Intuitive Surgical a Buy?

Boston Scientific

Costco

Amassing $1 million may be much more achievable than you think.

Investing in These Stocks Could Make You a Millionaire Retiree

Editas Medicine

Guardant Health Inc

Teladoc

Vertex Pharmaceuticals

SPDR S&P Biotech ETF

Why I'm Betting Big on This 1 Megatrend

Pandemic-fueled clampdowns on nonessential surgeries in key markets upset investors today.

Intuitive Surgical: Buy the Dip?

The stock market gave up ground as the week drew toward a close.

Strong Earnings Aren't Enough in This Stock Market -- Just Look at These 2 Stocks

Intuitive Surgical's (ISRG) fourth-quarter results reflect improvement in procedure volume.

Intuitive Surgical (ISRG) Q4 Earnings Beat Estimates, Up Y/Y

Novavax

Retractable Technologies

Investing in the recovery from the pandemic could pay off big.

These 3 Healthcare Stocks Are the Best Bets for 2021

Disney

Block

All three are already huge winners that have what it takes to survive and thrive over the long run.

3 Stocks to Buy and Hold for the Next 50 Years

Intuitive Surgical Inc. (NASDAQ: ISRG) reported its financial results for the fiscal fourth quarter on Thursday that came in better than expected. The company attributed its hawkish performance to a higher demand for its da Vinci surgical systems in recent months.

Intuitive Surgical's profit climbs to £267.29 million in fiscal Q4

Intuitive Surgical, Inc. (ISRG) CEO Gary Guthart on Q4 2020 Results - Earnings Call Transcript

Shares of Intuitive Surgical (NASDAQ:ISRG) were unchanged in after-market trading after the company reported Q4 results. Quarterly Results Earnings per share increased 2.87% year over year to $3.58, which beat the estimate of $3.12.

Intuitive Surgical: Q4 Earnings Insights

Intuitive Surgical (NASDAQ:ISRG) announces its next round of earnings this Thursday, January 21. Here is Benzinga's everything-that-matters guide for this Thursday's Q4 earnings announcement.

A Preview Of Intuitive Surgical's Earnings

Intuitive Surgical, a fast growing medical devices company, is scheduled to report its fiscal Q4 2020 results on Thursday, January 21. We expect Intuitive Surgical to likely beat the revenue and earnings expectations, driven by a strong rebound in total procedures.

Can Intuitive Surgical Stock Trend Higher After Q4 Release?

Fastenal

Procter & Gamble

UnitedHealth Group

Union Pacific

These 5 big cap stocks soared to new highs again in 2020. Can they continue to break out in 2021 as the COVID recovery takes hold?

5 Red-Hot Large Cap Earnings Superstars

Exelixis

Fastly

OrganiGram Holdings Inc.

Visa

Buying and holding innovative businesses is a time-tested way to build wealth.

Who's Ready to Get Rich? 5 Moneymaker Stocks to Buy Now

3 Fantastic Growth Stocks That Could Set You Up for Life

Intuitive Surgical (ISRG) posts solid fourth-quarter and full-year 2020 result driven mainly by da Vinci procedure volume growth.

Intuitive Surgical (ISRG) Up on Solid Preliminary Q4 Results

Intuitive Surgical, Inc. (ISRG) CEO Gary Guthart at 39th Annual J.P. Morgan Healthcare Conference (Transcript)

Sales are coming in stronger than expected. But what about earnings?

Why Intuitive Surgical Stock Just Popped

SUNNYVALE, CALIF., Jan. 13, 2021 (GLOBE NEWSWIRE) -- Intuitive (the “Company”) (Nasdaq: ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, today announced certain unaudited preliminary fourth quarter and full year 2020 financial results ahead of its participation at the 39th Annual JP Morgan Healthcare Conference on January 11-14, 2021.

Intuitive Announces Preliminary Fourth Quarter and Full Year 2020 Results

Booking Hlds

Lyft

An online travel giant, a next-gen medical device maker, and a gig economy laggard moved higher in 2020. They didn't earn those upticks.

3 Stocks That Did Not Deserve to Move Higher in 2020

Etsy

Fiverr

The businesses behind these stocks make them compellingly attractive.

My 3 Highest-Conviction Growth Stocks for 2021

Intuitive surgical's high-quality characteristics, overall market rally, and the low-rate environment keep pushing its stock higher. While the company could take advantage of it to raise capital, current investors have a reduced margin of safety. It is also hard for ISRG to deliver meaningful capital returns.

News for Intuitive Surgical Stock (ISRG)